M&A Deal Summary

Dipharma Francis S.r.l. Acquires Kalexsyn

On April 23, 2018, Dipharma Francis S.r.l. acquired life science company Kalexsyn

Acquisition Highlights
  • This is Dipharma Francis S.r.l.’s 1st transaction in the Life Science sector.
  • This is Dipharma Francis S.r.l.’s 1st transaction in the United States.
  • This is Dipharma Francis S.r.l.’s 1st transaction in Michigan.

M&A Deal Summary
Date 2018-04-23
Target Kalexsyn
Sector Life Science
Buyer(s) Dipharma Francis S.r.l.
Deal Type Add-on Acquisition

Target

Kalexsyn

Kalamazoo, Michigan, United States
Kalexsyn, Inc. is a provider of stable label synthesis, custom synthesis, process impurity synthesis, and process route development to biotechnology and pharmaceutical industry.

Search 201,292 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Dipharma Francis S.r.l.

Milan, Italy
Category Company
Sector Life Science
DESCRIPTION

Dipharma Francis S.r.l. is a provider of an active pharmaceutical Ingredients and crystalline forms for the most renowned pharmaceutical companies in USA, Europe, Japan, and other regions of the globe.

DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Add-on Acquisition) 1 of 1
State (Michigan) 1 of 1
Country (United States) 1 of 1
Year (2018) 1 of 1
Mergr

Product

Company

Legal